Natacha Gassenbach joined Biogen in October 2018 and is the Senior Vice President, Corporate Affairs, and Chief Communications Officer. She leads the global corporate affairs function, including external and internal communications, branding and reputation, corporate responsibility and patient advocacy. She also has responsibility for the Biogen Foundation and philanthropy. Prior to joining Biogen, she was head of corporate affairs at Baxalta (acquired by Shire), Novartis Vaccines and Diagnostics, and Boston Scientific.

Ms. Gassenbach spent more than 20 years in various leadership roles in the biopharmaceutical industry from early-stage companies to large corporations, with experience in medical devices, vaccines and pharmaceuticals. She led communications and engagement with key stakeholders during major complex transformations and participated in the launch of breakthrough therapies.

Ms. Gassenbach earned a master’s degree in journalism and communication from the University of Paris Sorbonne.

We cannot do
this alone

We hope that you join us on this journey to discover, develop and provide individualized antisense medicines for free for life for nano-rare patients. The ultimate personalized medicine approach – for free, for life.